[1]
Lieb K,Völlm B,Rücker G,Timmer A,Stoffers JM, Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials. The British journal of psychiatry : the journal of mental science. 2010 Jan; [PubMed PMID: 20044651]
[2]
Cohen JB,Gadde KM, Weight Loss Medications in the Treatment of Obesity and Hypertension. Current hypertension reports. 2019 Feb 12; [PubMed PMID: 30747357]
[3]
Kazerooni R,Lim J, Topiramate-Associated Weight Loss in a Veteran Population. Military medicine. 2016 Mar; [PubMed PMID: 26926755]
[4]
Raru Y,Zeid F, Hypoxic respiratory failure due to hyperammonemic encephalopathy induced by concurrent use of valproic acid and topiramate, a case report and review of the literature. Respiratory medicine case reports. 2018; [PubMed PMID: 29872630]
[5]
Castle D,Bosanac P,Rossell S, Treating OCD: what to do when first-line therapies fail. Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists. 2015 Aug; [PubMed PMID: 26104775]
[6]
Minton GC,Miller AD,Bookstaver PB,Love BL, Topiramate: safety and efficacy of its use in the prevention and treatment of migraine. Journal of central nervous system disease. 2011; [PubMed PMID: 23861645]
[7]
Arnone D, Review of the use of Topiramate for treatment of psychiatric disorders. Annals of general psychiatry. 2005 Feb 16; [PubMed PMID: 15845141]
[8]
Soyka M,Müller CA, Pharmacotherapy of alcoholism - an update on approved and off-label medications. Expert opinion on pharmacotherapy. 2017 Aug; [PubMed PMID: 28658981]
[9]
Parikh SK,Silberstein SD, Current Status of Antiepileptic Drugs as Preventive Migraine Therapy. Current treatment options in neurology. 2019 Mar 18; [PubMed PMID: 30880369]
[10]
Supuran CT, Drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors. Expert opinion on drug metabolism [PubMed PMID: 26878088]
[11]
Lauritzen M,Dreier JP,Fabricius M,Hartings JA,Graf R,Strong AJ, Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. 2011 Jan; [PubMed PMID: 21045864]
[12]
Vega D,Maalouf NM,Sakhaee K, Increased propensity for calcium phosphate kidney stones with topiramate use. Expert opinion on drug safety. 2007 Sep [PubMed PMID: 17877442]
[13]
Contin M,Riva R,Albani F,Avoni P,Baruzzi A, Topiramate therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs. Therapeutic drug monitoring. 2002 Jun; [PubMed PMID: 12021622]
[14]
Khalil NY,AlRabiah HK,Al Rashoud SS,Bari A,Wani TA, Topiramate: Comprehensive profile. Profiles of drug substances, excipients, and related methodology. 2019; [PubMed PMID: 31029222]
[15]
Alfaris N,Minnick AM,Hopkins CM,Berkowitz RI,Wadden TA, Combination phentermine and topiramate extended release in the management of obesity. Expert opinion on pharmacotherapy. 2015 Jun; [PubMed PMID: 25958964]
[16]
Novotny E,Renfroe B,Yardi N,Nordli D,Ness S,Wang S,Weber T,Kurland CL,Yuen E,Eerdekens M,Venkatraman L,Nye JS,Ford L, Randomized trial of adjunctive topiramate therapy in infants with refractory partial seizures. Neurology. 2010 Mar 2; [PubMed PMID: 20089937]
[17]
Kanner AM,Ashman E,Gloss D,Harden C,Bourgeois B,Bautista JF,Abou-Khalil B,Burakgazi-Dalkilic E,Llanas Park E,Stern J,Hirtz D,Nespeca M,Gidal B,Faught E,French J, Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2018 Jul 10; [PubMed PMID: 29898971]
[18]
Pulman J,Jette N,Dykeman J,Hemming K,Hutton JL,Marson AG, Topiramate add-on for drug-resistant partial epilepsy. The Cochrane database of systematic reviews. 2014 Feb 25; [PubMed PMID: 24570033]
[19]
Sierra-Rodríguez MA,Rodríguez-Vicente L,Chavarri-García JJ,Del Río-Mayor JL, Acute narrow-angle glaucoma induced by topiramate with acute myopia and macular striae: A case report. Archivos de la Sociedad Espanola de Oftalmologia. 2019 Mar; [PubMed PMID: 30591244]
[20]
Karachristianou S,Papamichalis E,Sarantopoulos A,Boura P,Georgiadis G, Hypohidrosis induced by topiramate in an adult patient. Epileptic disorders : international epilepsy journal with videotape. 2013 Jun; [PubMed PMID: 23773932]
[21]
Gupta S,Gao JJ,Emmett M,Fenves AZ, Topiramate and metabolic acidosis: an evolving story. Hospital practice (1995). 2017 Dec; [PubMed PMID: 28828886]
[22]
Abraham G, Topiramate-induced suicidality. Canadian journal of psychiatry. Revue canadienne de psychiatrie. 2003 Mar; [PubMed PMID: 12655915]
[23]
Pietrzak B,Konopka A,Wojcieszak J, Effect of topiramate on hippocampus-dependent spatial memory in rats. Pharmacological reports : PR. 2013; [PubMed PMID: 24399711]
[24]
Campbell E,Devenney E,Morrow J,Russell A,Smithson WH,Parsons L,Robertson I,Irwin B,Morrison PJ,Hunt S,Craig J, Recurrence risk of congenital malformations in infants exposed to antiepileptic drugs in utero. Epilepsia. 2013 Jan; [PubMed PMID: 23167802]
[25]
Salek T,Andel I,Kurfurstova I, Topiramate induced metabolic acidosis and kidney stones - a case study. Biochemia medica. 2017 Jun 15; [PubMed PMID: 28694730]
[26]
Golpayegani M,Salari F,Gharagozli K, Newer Antiepileptic Drugs Discontinuation due to Adverse Effects: An Observational Study. Annals of Indian Academy of Neurology. 2019 Jan-Mar; [PubMed PMID: 30692756]
[27]
Yamamoto Y,Usui N,Nishida T,Mori M,Takahashi Y,Imai K,Kagawa Y,Inoue Y, Influence of Renal Function on Pharmacokinetics of Antiepileptic Drugs Metabolized by CYP3A4 in a Patient With Renal Impairment. Therapeutic drug monitoring. 2018 Feb; [PubMed PMID: 29095797]
[28]
Asconapé JJ, Use of antiepileptic drugs in hepatic and renal disease. Handbook of clinical neurology. 2014; [PubMed PMID: 24365310]
[30]
Bourgeois BF, Pharmacokinetics and metabolism of topiramate. Drugs of today (Barcelona, Spain : 1998). 1999 Jan; [PubMed PMID: 12973408]
[31]
Wiśniewski M,Łukasik-Głebocka M,Anand JS, Acute topiramate overdose--clinical manifestations. Clinical toxicology (Philadelphia, Pa.). 2009 Apr [PubMed PMID: 19514879]
[32]
Wittich CM,Burkle CM,Lanier WL, Ten common questions (and their answers) about off-label drug use. Mayo Clinic proceedings. 2012 Oct; [PubMed PMID: 22877654]